{"entity":{"id":"idea-acc-oncology-pharmacist-prescribing","kind":"idea","name":"Oncology pharmacists as protocol prescribers for supportive care and dose adjustments","aka":[],"tldr":"Let specially trained cancer pharmacists prescribe anti-sickness drugs, growth-factor support and routine dose adjustments under protocols, freeing oncologists for decisions only they can make.","summary":"Oncology pharmacists already check every chemotherapy prescription; in several countries (UK, parts of Canada and the US) they hold independent or collaborative prescribing rights for supportive medicines and protocol dose modifications. Extending this model widely, with a defined competency framework, removes a large fraction of routine prescribing from oncologists' clinics and shortens chair waits caused by prescription queries.","asOf":"2026-09-08","links":[{"label":"Bottleneck evidence (Not enough oncologists, nurses, pathologists, physicists): Yang et al., Projected supply of and demand for oncologists and radiation oncologists through 2025 (JOP 2014)","url":"https://doi.org/10.1200/JOP.2013.001319"}],"tags":[],"related":[],"cancers":[],"sections":["chemotherapy","supportive-care"],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":["b-workforce","b-care-fragmentation"],"keyPapers":["paper-yang-j-oncol-pract"],"journals":[],"dependsOn":[],"notes":[],"hypothesis":"Units with pharmacist protocol prescribing will reduce oncologist time per chemotherapy cycle by at least 20% and reduce day-of-treatment prescription delays by half, with no increase in medication errors.","rationale":"Pharmacists are the profession with the deepest drug-dosing training; collaborative prescribing has shown equivalent safety in anticoagulation, diabetes, and HIV care.","test":"A twelve-month before-and-after study across five day units with time-motion measurement, delay logs, and an independent error audit.","maturity":"early-clinical","actor":"regulator","cost":"small","horizonYears":2},"route":"/ideas/idea-acc-oncology-pharmacist-prescribing/","neighbours":{"section":[{"id":"chemotherapy","kind":"section","name":"Chemotherapy","route":"/fronts/chemotherapy/"},{"id":"supportive-care","kind":"section","name":"Supportive Care & Survivorship","route":"/fronts/supportive-care/"}],"bottleneck":[{"id":"b-care-fragmentation","kind":"bottleneck","name":"Fragmented care and guideline gaps","route":"/bottlenecks/b-care-fragmentation/"},{"id":"b-workforce","kind":"bottleneck","name":"Not enough oncologists, nurses, pathologists, physicists","route":"/bottlenecks/b-workforce/"}],"paper":[{"id":"paper-yang-j-oncol-pract","kind":"paper","name":"Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage","route":"/key-papers/paper-yang-j-oncol-pract/"}],"idea":[{"id":"idea-acc-structured-deprescribing-at-diagnosis","kind":"idea","name":"Structured deprescribing review at cancer diagnosis and again at transition to palliative care","route":"/ideas/idea-acc-structured-deprescribing-at-diagnosis/"}]}}